Annual Gross Profit
$28.54 B
+$1.46 B+5.38%
December 1, 2024
Summary
- As of February 7, 2025, GSK annual gross profit is $28.54 billion, with the most recent change of +$1.46 billion (+5.38%) on December 1, 2024.
- During the last 3 years, GSK annual gross profit has risen by +$5.79 billion (+25.46%).
- GSK annual gross profit is now -18.65% below its all-time high of $35.08 billion, reached on December 31, 2007.
Performance
GSK Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Profit
$7.31 B
+$36.52 M+0.50%
September 30, 2024
Summary
- As of February 7, 2025, GSK quarterly gross profit is $7.31 billion, with the most recent change of +$36.52 million (+0.50%) on September 30, 2024.
- Over the past year, GSK quarterly gross profit has dropped by -$132.89 million (-1.79%).
- GSK quarterly gross profit is now -40.58% below its all-time high of $12.30 billion, reached on September 30, 2003.
Performance
GSK Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Gross Profit
$28.41 B
-$132.89 M-0.47%
September 30, 2024
Summary
- As of February 7, 2025, GSK TTM gross profit is $28.41 billion, with the most recent change of -$132.89 million (-0.47%) on September 30, 2024.
- Over the past year, GSK TTM gross profit has increased by +$2.28 billion (+8.72%).
- GSK TTM gross profit is now -19.10% below its all-time high of $35.12 billion, reached on March 31, 2008.
Performance
GSK TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
GSK Gross Profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +5.4% | -1.8% | +8.7% |
3 y3 years | +25.5% | +21.8% | +18.8% |
5 y5 years | +2.1% | +21.8% | +18.8% |
GSK Gross Profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +25.5% | -1.8% | +26.3% | -0.5% | +18.8% |
5 y | 5-year | at high | +35.4% | -3.2% | +1477.5% | -2.2% | +54.4% |
alltime | all time | -18.6% | +324.3% | -40.6% | +1477.5% | -19.1% | +948.9% |
GSK Gross Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $28.54 B(+5.4%) | - | - |
Sep 2024 | - | $7.31 B(+0.5%) | $28.41 B(-0.5%) |
Jun 2024 | - | $7.27 B(+6.3%) | $28.55 B(+2.5%) |
Mar 2024 | - | $6.84 B(-2.2%) | $27.84 B(+2.8%) |
Dec 2023 | $27.08 B(+10.6%) | $7.00 B(-5.9%) | $27.09 B(+3.7%) |
Sep 2023 | - | $7.44 B(+13.3%) | $26.13 B(+4.3%) |
Jun 2023 | - | $6.57 B(+7.9%) | $25.06 B(+2.4%) |
Mar 2023 | - | $6.09 B(+0.8%) | $24.47 B(+0.4%) |
Dec 2022 | $24.48 B(+7.6%) | $6.04 B(-5.0%) | $24.38 B(+1.1%) |
Sep 2022 | - | $6.36 B(+6.5%) | $24.12 B(+0.0%) |
Jun 2022 | - | $5.98 B(-0.4%) | $24.12 B(+0.8%) |
Mar 2022 | - | $6.00 B(+3.7%) | $23.92 B(-3.3%) |
Dec 2021 | $22.75 B(+7.9%) | $5.78 B(-9.0%) | $24.72 B(+34.3%) |
Sep 2021 | - | $6.36 B(+10.1%) | $18.41 B(-5.6%) |
Jun 2021 | - | $5.77 B(-15.2%) | $19.49 B(-3.2%) |
Mar 2021 | - | $6.81 B(-1383.3%) | $20.14 B(-3.6%) |
Dec 2020 | $21.08 B(-24.6%) | -$530.41 M(-107.1%) | $20.88 B(-27.2%) |
Sep 2020 | - | $7.44 B(+16.0%) | $28.69 B(-0.4%) |
Jun 2020 | - | $6.42 B(-15.0%) | $28.81 B(-0.8%) |
Mar 2020 | - | $7.55 B(+3.7%) | $29.04 B(+4.1%) |
Dec 2019 | $27.95 B(+1.8%) | $7.28 B(-3.8%) | $27.91 B(+1.7%) |
Sep 2019 | - | $7.57 B(+13.8%) | $27.44 B(+1.7%) |
Jun 2019 | - | $6.65 B(+3.5%) | $26.98 B(-0.6%) |
Mar 2019 | - | $6.42 B(-5.7%) | $27.15 B(-1.1%) |
Dec 2018 | $27.46 B(+7.2%) | $6.81 B(-4.2%) | $27.45 B(+0.2%) |
Sep 2018 | - | $7.11 B(+4.3%) | $27.39 B(+1.2%) |
Jun 2018 | - | $6.81 B(+1.4%) | $27.07 B(+3.1%) |
Mar 2018 | - | $6.72 B(-0.4%) | $26.27 B(+2.7%) |
Dec 2017 | $25.62 B(+1.7%) | $6.75 B(-0.7%) | $25.58 B(+1.7%) |
Sep 2017 | - | $6.80 B(+13.1%) | $25.15 B(+0.8%) |
Jun 2017 | - | $6.01 B(-0.4%) | $24.94 B(-1.3%) |
Mar 2017 | - | $6.03 B(-4.4%) | $25.26 B(+0.7%) |
Dec 2016 | $25.20 B(+9.4%) | $6.31 B(-4.3%) | $25.09 B(+2.6%) |
Sep 2016 | - | $6.59 B(+4.1%) | $24.47 B(+2.1%) |
Jun 2016 | - | $6.33 B(+8.0%) | $23.95 B(+1.6%) |
Mar 2016 | - | $5.86 B(+3.2%) | $23.57 B(+2.3%) |
Dec 2015 | $23.03 B(-10.9%) | $5.68 B(-6.6%) | $23.04 B(-3.7%) |
Sep 2015 | - | $6.08 B(+2.2%) | $23.94 B(-1.2%) |
Jun 2015 | - | $5.95 B(+11.5%) | $24.23 B(-2.1%) |
Mar 2015 | - | $5.33 B(-18.9%) | $24.74 B(-4.1%) |
Dec 2014 | $25.85 B(-7.8%) | $6.58 B(+3.2%) | $25.81 B(-2.0%) |
Sep 2014 | - | $6.37 B(-1.4%) | $26.33 B(-1.7%) |
Jun 2014 | - | $6.46 B(+0.9%) | $26.77 B(-2.5%) |
Mar 2014 | - | $6.40 B(-9.7%) | $27.45 B(-2.1%) |
Dec 2013 | $28.04 B(-4.4%) | $7.09 B(+3.9%) | $28.03 B(-2.1%) |
Sep 2013 | - | $6.82 B(-4.4%) | $28.62 B(-0.6%) |
Jun 2013 | - | $7.14 B(+2.2%) | $28.81 B(+0.3%) |
Mar 2013 | - | $6.98 B(-9.1%) | $28.73 B(-2.0%) |
Dec 2012 | $29.32 B(-7.4%) | $7.68 B(+9.6%) | $29.32 B(-0.8%) |
Sep 2012 | - | $7.01 B(-0.8%) | $29.55 B(-3.5%) |
Jun 2012 | - | $7.06 B(-6.7%) | $30.62 B(-3.3%) |
Mar 2012 | - | $7.57 B(-4.2%) | $31.68 B(+0.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2011 | $31.65 B(+0.2%) | $7.90 B(-2.3%) | $31.66 B(+1.0%) |
Sep 2011 | - | $8.08 B(-0.4%) | $31.36 B(+1.6%) |
Jun 2011 | - | $8.12 B(+7.5%) | $30.87 B(+0.4%) |
Mar 2011 | - | $7.55 B(-0.7%) | $30.76 B(-2.8%) |
Dec 2010 | $31.59 B(-3.9%) | $7.60 B(+0.0%) | $31.64 B(-6.4%) |
Sep 2010 | - | $7.60 B(-5.0%) | $33.79 B(-1.6%) |
Jun 2010 | - | $8.00 B(-5.1%) | $34.35 B(+0.4%) |
Mar 2010 | - | $8.43 B(-13.6%) | $34.20 B(+3.9%) |
Dec 2009 | $32.87 B(-0.9%) | $9.76 B(+19.6%) | $32.94 B(+6.5%) |
Sep 2009 | - | $8.16 B(+3.9%) | $30.93 B(+0.2%) |
Jun 2009 | - | $7.85 B(+9.7%) | $30.88 B(-2.4%) |
Mar 2009 | - | $7.16 B(-7.7%) | $31.63 B(-4.2%) |
Dec 2008 | $33.17 B(-5.4%) | $7.76 B(-4.4%) | $33.03 B(-4.0%) |
Sep 2008 | - | $8.11 B(-5.6%) | $34.40 B(-1.3%) |
Jun 2008 | - | $8.60 B(+0.5%) | $34.86 B(-0.7%) |
Mar 2008 | - | $8.56 B(-6.2%) | $35.12 B(+0.1%) |
Dec 2007 | $35.08 B(+4.5%) | $9.13 B(+6.4%) | $35.08 B(+1.4%) |
Sep 2007 | - | $8.58 B(-3.2%) | $34.60 B(+0.9%) |
Jun 2007 | - | $8.86 B(+4.0%) | $34.31 B(+1.3%) |
Mar 2007 | - | $8.52 B(-1.5%) | $33.87 B(+1.0%) |
Dec 2006 | $33.57 B(+9.2%) | $8.64 B(+4.4%) | $33.54 B(+1.8%) |
Sep 2006 | - | $8.28 B(-1.6%) | $32.94 B(+1.9%) |
Jun 2006 | - | $8.42 B(+2.8%) | $32.33 B(+2.7%) |
Mar 2006 | - | $8.19 B(+1.8%) | $31.49 B(+2.6%) |
Dec 2005 | $30.73 B(+7.4%) | $8.05 B(+4.9%) | $30.69 B(+1.6%) |
Sep 2005 | - | $7.67 B(+1.2%) | $30.21 B(+2.4%) |
Jun 2005 | - | $7.58 B(+2.6%) | $29.49 B(+1.7%) |
Mar 2005 | - | $7.39 B(-2.3%) | $29.01 B(+1.3%) |
Dec 2004 | $28.63 B(+3.7%) | $7.57 B(+8.9%) | $28.63 B(+27.5%) |
Sep 2004 | - | $6.95 B(-2.0%) | $22.46 B(-19.2%) |
Jun 2004 | - | $7.09 B(+1.1%) | $27.80 B(+0.7%) |
Mar 2004 | - | $7.02 B(+403.7%) | $27.62 B(+1.3%) |
Dec 2003 | $27.60 B(+10.6%) | $1.39 B(-88.7%) | $27.26 B(-16.9%) |
Sep 2003 | - | $12.30 B(+77.9%) | $32.81 B(+23.6%) |
Jun 2003 | - | $6.91 B(+3.8%) | $26.54 B(+2.4%) |
Mar 2003 | - | $6.66 B(-4.0%) | $25.93 B(+3.9%) |
Dec 2002 | $24.95 B(+7.6%) | $6.94 B(+15.2%) | $24.96 B(+1.7%) |
Sep 2002 | - | $6.03 B(-4.3%) | $24.55 B(+2.1%) |
Jun 2002 | - | $6.30 B(+10.5%) | $24.05 B(+2.5%) |
Mar 2002 | - | $5.70 B(-12.8%) | $23.45 B(+1.2%) |
Dec 2001 | $23.18 B(+8.3%) | $6.53 B(+18.1%) | $23.18 B(+4.0%) |
Sep 2001 | - | $5.53 B(-3.0%) | $22.28 B(+1.7%) |
Jun 2001 | - | $5.70 B(+5.1%) | $21.91 B(+1.5%) |
Mar 2001 | - | $5.42 B(-3.8%) | $21.59 B(+1.1%) |
Dec 2000 | $21.40 B(+218.2%) | $5.63 B(+9.3%) | $21.35 B(+35.9%) |
Sep 2000 | - | $5.15 B(-4.2%) | $15.71 B(+48.8%) |
Jun 2000 | - | $5.38 B(+3.9%) | $10.56 B(+31.4%) |
Mar 2000 | - | $5.18 B(+81.2%) | $8.04 B(+181.2%) |
Dec 1999 | $6.72 B(-37.0%) | - | - |
Jun 1999 | - | $2.86 B(+5.5%) | $2.86 B(+5.5%) |
Dec 1998 | $10.67 B(+21.3%) | - | - |
Jun 1998 | - | $2.71 B | $2.71 B |
Jun 1995 | $8.80 B | - | - |
FAQ
- What is GSK annual gross profit?
- What is the all time high annual gross profit for GSK?
- What is GSK annual gross profit year-on-year change?
- What is GSK quarterly gross profit?
- What is the all time high quarterly gross profit for GSK?
- What is GSK quarterly gross profit year-on-year change?
- What is GSK TTM gross profit?
- What is the all time high TTM gross profit for GSK?
- What is GSK TTM gross profit year-on-year change?
What is GSK annual gross profit?
The current annual gross profit of GSK is $28.54 B
What is the all time high annual gross profit for GSK?
GSK all-time high annual gross profit is $35.08 B
What is GSK annual gross profit year-on-year change?
Over the past year, GSK annual gross profit has changed by +$1.46 B (+5.38%)
What is GSK quarterly gross profit?
The current quarterly gross profit of GSK is $7.31 B
What is the all time high quarterly gross profit for GSK?
GSK all-time high quarterly gross profit is $12.30 B
What is GSK quarterly gross profit year-on-year change?
Over the past year, GSK quarterly gross profit has changed by -$132.89 M (-1.79%)
What is GSK TTM gross profit?
The current TTM gross profit of GSK is $28.41 B
What is the all time high TTM gross profit for GSK?
GSK all-time high TTM gross profit is $35.12 B
What is GSK TTM gross profit year-on-year change?
Over the past year, GSK TTM gross profit has changed by +$2.28 B (+8.72%)